Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Plos One|November 9, 2013
Administration of heme arginate ameliorates murine type 2 diabetes independently of heme oxygenase activityAbhijeet K Choudhary, Jillian Rennie, Carolynn Cairns, et al.Kidney International|June 22, 2012
Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factorsBryan R Conway, Deepika Manoharan, Divya Manoharan, et al.Nephrology (Carlton, Vic.)|September 9, 2014
Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosisBryan R Conway, Boris Betz, Tara A Sheldrake, et al.Journal of the American Society of Nephrology : JASN|December 24, 2011
Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathyBryan R Conway, Jillian Rennie, Matthew A Bailey, et al.Diabetes|March 30, 2004
Association between variation in the actin-binding gene caldesmon and diabetic nephropathy in type 1 diabetesBryan R Conway, A Peter Maxwell, David A Savage, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 9, 2024
Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation StudyEmilie J Lambourg, Edouard L Fu, Stuart McGurnaghan, et al.Diabetologia|May 22, 2017
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetesSara J Jenks, Bryan R Conway, Stela McLachlan, et al.Journal of the American Society of Nephrology : JASN|October 26, 2013
MicroRNA-214 antagonism protects against renal fibrosisLaura Denby, Vasudev Ramdas, Ruifang Lu, et al.Kidney International Reports|February 22, 2021
A National Registry Study of Patient and Renal Survival in Adult Nephrotic SyndromeAnna Kolb, Peter J Gallacher, Jacqueline Campbell, et al.Kidney International|April 17, 2016
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetesBoris B Betz, Sara J Jenks, Andrew D Cronshaw, et al.Pageof 3